A scientific rationale for protective therapy in Parkinson's diseaseOLANOW, C. W.Journal of neural transmission. 1993, Vol 91, Num 2-3, pp 161-180, issn 0300-9564Article

A radical hypothesis for neurodegenerationOLANOW, C. W.Trends in neurosciences (Regular edition). 1993, Vol 16, Num 11, pp 439-444, issn 0166-2236Article

Magnetic resonance imaging in ParkinsonismOLANOW, C. W.Neurologic clinics. 1992, Vol 10, Num 2, pp 405-420, issn 0733-8619Article

A 61-year-old man with Parkinson's diseaseOLANOW, C. W.JAMA, the journal of the American Medical Association. 1996, Vol 275, Num 9, pp 716-722, issn 0098-7484Article

MAO-B inhibitors in Parkinson's diseaseOLANOW, C. W.Advances in neurology. 1993, Vol 60, pp 666-671, issn 0091-3952Article

A new approach to late onset myasthenia gravisOLANOW, C. W; ROSES, A.Geriatrics. 1984, Vol 39, Num 1, pp 91-99, issn 0016-867XArticle

Tolcapone and hepatotoxic effectsOLANOW, C. W.Archives of neurology (Chicago). 2000, Vol 57, Num 2, pp 263-267, issn 0003-9942Article

Early therapy for Parkinson's diseaseOLANOW, C. W.European neurology. 1992, Vol 32, pp 30-35, issn 0014-3022, SUP1Conference Paper

Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms ?OLANOW, C. W; CALNE, D.Neurology. 1992, Vol 42, Num 4, pp 13-26, issn 0028-3878, SUP4Article

Etiology and pathogenesis of Parkinson's diseaseOLANOW, C. W; TATTON, W. G.Annual review of neuroscience. 1999, Vol 22, pp 123-144, issn 0147-006XArticle

Parkinsonism and amiodarone therapyWERNER, E. G; OLANOW, C. W.Annals of neurology. 1989, Vol 25, Num 6, pp 630-632, issn 0364-5134Article

L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitroMYTILINEOU, C; RADCLIFFE, P. M; OLANOW, C. W et al.Journal of neurochemistry. 1997, Vol 68, Num 1, pp 434-436, issn 0022-3042Article

Oxidative stress in Parkinson's diseaseOLANOW, C. W.Clinical neuropharmacology. 1997, Vol 20, pp S3-S7, issn 0362-5664, SUP1Conference Paper

Attempts to obtain neuroprotection in Parkinson's diseaseOLANOW, C. W.Neurology. 1997, Vol 49, Num 1, pp S26-S33, issn 0028-3878, SUP1Conference Paper

Selegiline : Current perspectives on issues related to neuroprotection and mortalityOLANOW, C. W.Neurology. 1996, Vol 47, Num 6, pp S210-S216, issn 0028-3878, SUP3Article

orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's diseaseHAUSER, R. A; OLANOW, C. W.Movement disorders. 1993, Vol 8, Num 4, pp 512-514, issn 0885-3185Article

A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseOLANOW, C. W.Movement disorders. 1993, Vol 8, pp S1-S7, issn 0885-3185, SUP1Conference Paper

Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseCEDARBAUM, J. M; OLANOW, C. W.Neurology. 1991, Vol 41, Num 10, pp 1567-1570, issn 0028-3878Article

Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's diseaseOLANOW, C. W; ALBERTS, M. J.Clinical neuropharmacology. 1987, Vol 10, Num 2, pp 178-185, issn 0362-5664Article

An introduction to the free radical hypothesis in Parkinson's diseaseOLANOW, C. W.Annals of neurology. 1992, Vol 32, pp S2-S9, issn 0364-5134, SUPConference Paper

Waking up to sleep episodes in Parkinson's diseaseOLANOW, C. W; SCHAPIRA, A. H. V; ROTH, T et al.Movement disorders. 2000, Vol 15, Num 2, pp 212-215, issn 0885-3185Article

Fetal nigral transplantation as a therapy for Parkinson's diseaseOLANOW, C. W; KORDOWER, J. H; FREEMAN, T. B et al.Trends in neurosciences (Regular edition). 1996, Vol 19, Num 3, pp 102-109, issn 0166-2236Article

Progressive dementia and gait disorder in a 78 year old womanTAGLIATI, M; PERL, D. P; DRAYER, B et al.Journal of neurology, neurosurgery and psychiatry. 2000, Vol 68, Num 4, pp 526-531, issn 0022-3050Article

Oxidative stress and the pathogenesis of Parkinson's diseaseJENNER, P; OLANOW, C. W.Neurology. 1996, Vol 47, Num 6, pp S161-S170, issn 0028-3878, SUP3Article

Free radicals and neurodegeneration. Author's replyCADET, J. L; OLANOW, C. W; PERL, D. P et al.Trends in neurosciences (Regular edition). 1994, Vol 17, Num 5, pp 192-194, issn 0166-2236Article